wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33388196-3EDBAEF7-27AA-484F-9876-E9371FC6766A
Q33388196-3EDBAEF7-27AA-484F-9876-E9371FC6766A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33388196-3EDBAEF7-27AA-484F-9876-E9371FC6766A
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia
P2860
Q33388196-3EDBAEF7-27AA-484F-9876-E9371FC6766A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33388196-3EDBAEF7-27AA-484F-9876-E9371FC6766A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2f137528059f11639731b31caa905b330fa3c65
P2860
Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.